Lotus Eye Hospital & Institute Ltd Directors Report.
Your Directors have pleasure in presenting the 22nd Annual Report of your Company together with the audited accounts for the year ended 31st March 2019.
(Rs in Lakhs )
|Particulars||31.03.2019 (Current year)||31.03.2018 (Previous year)|
|Income from Operations and other income||3910.28||3888.57|
|less : Expenses||3847.43||3722.51|
|Add/less: Exceptional items||(0.06)||4.18|
|Profit / (Loss) before Tax||62.79||170.24|
|Less : Provision for Taxes :|
|Profit / (Loss) after tax||70.81||174.67|
REVIEW OF OPERATIONS AND PERFORMANCE:
your company has reported a growth of 0.6% on turnover of Rs. 3910.28 Lakhs during the financial year 2018-19 compared to the turnover of Rs 3888.57 lakhs in the previous financial year 2017-18.your Company has a net profit of Rs. 70.81 lakhs for the financial year 2018-19 as compared to Rs. 174.67 lakhs for the financial year 2017-18.
Y our directors are putting consistent effort to increase the turnover and net profit so that the Company can meet the expectations of the stakeholders.
The Board of directors and the management, after in depth analysis of the financial position of the company have decided not to declare divided for the financial year 2018-19, as it would put a further financial strain on the company, but are very positive for the next financial year.
The Paid up equity share capital as on 31st March, 2019 is 2,079.63 lakhs. during the year under review, the Company has not issued any shares to the Shareholders. The company has neither issued shares with differential voting rights nor granted stock options or sweat equity shares.
Cash and cash equivalents as at 31st March, 2019 was 259.28 lakhs. The Company continues to focus on judicious management of its working capital, receivables, inventories and other working capital parameters which are kept under strict check through continuous monitoring.
TRANSFER TO RESERVES:
Consequence to the inadequate profits, your company has not transferred any amount to reserve.
during the year under review, your company has not accepted any deposits from public covered under Sections 73 to76 or any other relevant provisions of the Act and rules framed thereunder.
PARTICULARS OF LOANS, GUARANTEES OR INVESTMENTS:
during the year under review, your Company has not given any loans or guarantees covered under the provisions of section 186 of the Companies Act, 2013.
The detail of the investments made by the company is given in the notes to the financial statements.
OUTLOOK FOR THE CURRENT YEAR:
Your company will envisions, envisage and foresee to accomplish and percolate ascendency in all established centers in the coming financial year, accent and weight shall be given to improving quality of services and customer satisfaction, as consumers and stakeholders are the onus of the brand Lotus in eye care facilities and specialty.
Protuberant and extrusive steps in direction to establish art of the centre signature eye clinics across South India shall be taken. CORPORATE SOCIAL RESPONSIBILITIES:
your company does not falls within the bracket as prescribed by Section 135 of the Companies Act, 2013 and rules framed thereunder. Hence this clause is not applicable.
Directors retiring by rotation:
Dr. Kavetha Sundaramoorthy (Din: 02050806), director of the Company retires by rotation at the forthcoming Annual General Meeting and being eligible, offers herself for re-appointment.
Information regarding the directors seeking appointment / re-appointment:
Resume and other information regarding the directors seeking appointment /re-appointment as required by Regulation 36 of the SEBI (LODR) Regulations, 2015 has been given in the Notice convening the 22nd Annual General Meeting and in the Statement pursuant to Section 102 of the Act.
Declaration by Independent Directors:
All Independent directors have given declaration that they meet the criteria of independence as laid down under section 149(6) of the Companies Act, 2013 and regulation 16(b) of SEBI (listing Obligations and disclosure Requirements) Regulations, 2015.
your Company has adopted policy on Familiarization programme of Independent directors. during the year under review one programme was conducted by the company details of such programme for familiarisation of the Independent directors are put on the website of the Company at the following web-link : https://www.lotuseye.org/investors
None of the directors of the Company are disqualified as per the applicable provisions of the Act.
Pursuant to the provisions of Companies Act, 2013 and SEBI (listing Obligation and disclosure Requirements) Regulations, 2015, the Board has carried out an evaluation of its own performance, the directors individually as well as evaluation of the working of its Committees.
The criteria for performance evaluation are as under:
Performance Evaluation of Board:
Key Parameters: degree of fulfillment of key responsibilities; Board structure and composition; Establishment and delineation of responsibilities to Committees; Effectiveness of Board processes, information and functioning; Board Culture and dynamics; Quality of relationship between the Board and the Management; Efficacy of communication with external stakeholders, etc.
Self Assessment of the Performance by Individual directors (including Independent director):
Key Parameters: Attendance at meetings; contribution at meetings; independence of judgment; direction / guidance to senior management, etc.
Self Assessment of the Performance by the Board Level Committees:
Key Parameters: Degree of fulfillment of key responsibilities; Adequacy of Committee Composition; Effectiveness of meetings; Committee dynamics; Quality of relationship of the committee with the Board and the management, etc.
The directors have expressed their satisfaction with the evaluation process.
The Policy on Board diversity and Nomination & Remuneration Policy as recommended by the Nomination & Remuneration Committee have been approved by the Board of directors. The said policies are annexed to the Boards Report as "Annexure- VI" and are also available on the Companys website at the following link: https://www.lotuseye.org/ investors.
During the year, four Board Meetings, four Audit Committee Meetings, one Nomination and Remuneration Committee Meetings were held and The Stakeholder Relationship Committee Meeting for the financial year 2018-19 was held on 28th May, 2019. The details of these meetings are given in the Corporate Governance Report. The intervening gap between the Meetings was within the period prescribed under the Companies Act, 2013 and Secretarial Standard. The independent directors meeting was held once in the financial year on 12th February, 2018.
COMMITTEES OF THE BOARD:
Currently the Company has three Committees i.e. Audit Committee, Nomination and Remuneration Committee and Stakeholders Relationship Committee. All the committees are Independent under the Chairmanship of an Independent Director. The details of the compositions, terms of reference, meetings, etc., of said Committees are given in the Report on Corporate Governance which forms part of this Report.
DIRECTORS RESPONSIBILITY STATEMENT:
In terms of Section 134 (5) of the Companies Act, 2013, the Directors would like to state that:
I. In the preparation of the annual accounts the applicable accounting standards have been followed.
II. Appropriate accounting policies have been selected and applied consistently, and judgments and estimates that have been made are reasonable and prudent so as to give a true and fair view of the company at the end of the financial year and of the company for that period.
III. Proper and sufficient care has been taken for the maintenance of adequate accounting records in accordance with the provisions of the companies Act, 2013 for safeguarding the assets of the company and for the preventing and detecting fraud and other irregularities.
IV. Annual accounts have been prepared on going concern basis.
V. They had laid down Internal financial controls to be followed by the company and that such internal financial control are adequate and were operating effectively.
VI. They had devised proper system to ensure compliance with the provisions of all applicable laws and that such system were adequate and operating effectively.
RELATED PARTY TRANSACTIONS:
All related party transactions that were entered into during the financial year were on an arms length basis and were in the ordinary course of the business. There are no materially significant related party transactions made by the company with Promoters, Key Managerial Personnel or other designated persons which may have potential conflict with interest of the company at large. Accordingly, no transactions are being reported in Form AOC-2 in terms of Section 134 of the Act, read with Rule 8 of the Companies (Accounts) Rules, 2014.
INTERNAL FINANCIAL CONTROL AND ITS ADEQUACY:
The Board reviews from time to time the adequacy and effectiveness of the Companys internal financial controls. This year was no exception. The reviews conducted during the year did not reveal any material deficiencies in the internal financial control structure.
SIGNIFICANT MATERIAL ORDERS PASSED BY THE REGULATORS OR COURTS OR TRIBUNALS:
There is no significant and material orders passed by the Regulators / Courts / Tribunals which would impact the going concern status and Companys operations in future.
The Company does not have any subsidiary company.
CHANGE IN NATURE OF BUSINESS, IF ANY:
During the year under review, there is no change in nature of business of the Company.
MATERIAL CHANGES AND COMMITMENTS AFFECTING THE FINANCIAL POSITION OF THE COMPANY:
There are no material changes and commitments affecting financial position of the Company which have occurred between the end of the financial year of the Company to which the Financial Statements relate and date of the report.
CODE OF CONDUCT:
The Board of directors have approved a Code of Conduct which is applicable to the Members of the Board and all employees in the course of day to day business operations of the company. The Company believes in "Zero Tolerance" against bribery, corruption and unethical dealings / behaviors of any form and the Board has laid down the directives to counter such acts. The code laid down by the Board is known as "Code of Conduct for Board of Directors and Senior Executives". The Code has also been posted on the Companys website at the following link: https:// www.lotuseye.org/ investors.
The Code lays down the standard procedure of business conduct which is expected to be followed by the Directors and the designated employees in their business dealings and in particular on matters relating to integrity in the work place, in business practices and in dealing with stakeholders. The Code gives guidance through examples on the expected behavior from an employee in a given situation and the reporting structure.
All the Board Members and the Senior Management personnel have confirmed compliance with the Code. All Management Staff were given appropriate training in this regard.
KEY MANAGERIAL PERSONNEL:
The details of the Key Managerial Personnel of the Company, their appointment / cessation during the year under review and remuneration are given in the Extract of Annual Return annexed hereto and forming a part of this Report.
VIGIL MECHANISM / WHISTLE BLOWER POLICY:
Your Company believes in the conduct of the affairs of its constituents in a fair and transparent manner by adopting highest standards of professionalism, honesty, integrity and ethical behaviour.
Your Company is committed to developing a culture where it is safe for any Whistle Blower to raise concerns about any poor or unacceptable practice and any event of misconduct. The alleged misconduct may be classified in many ways; namely, violation of a law, rule, regulation and / or a direct threat to public interest, such as health and safety violations and corruption.
Your Company will not tolerate any form of victimization and will take appropriate steps to protect a bona fide whistle blower and shall treat any retaliation as a serious disciplinary offence that merits disciplinary action. The Company will protect the identity of the whistle blower, if so desired, provided that the whistle blower will need to attend any disciplinary hearing or proceedings as may be required for investigation of the complaint. The mechanism provides for a detailed complaint and investigation process. If circumstances so require, the employee can make complaint directly to the Chairman of the Audit Committee. The said mechanism can also be availed by the Directors of the Company.
Whistle Blower Policy of your Company is available on the website of the Company at the following link: https://www.lotuseye.org/investors
PREVENTION OF INSIDER TRADING:
The Company has adopted a Code of Conduct for Prevention of Insider Trading with a view to regulate trading in securities by the Directors and designated employees of the Company. The Code requires pre-clearance for dealing in the Companys shares and prohibits the purchase or sale of Company shares by the Directors and the designated
employees while in possession of unpublished price sensitive information in relation to the Company and during the period when the Trading Window is closed. The Board is responsible for implementation of the Code.
The same Code is available in the website of your Company at the following link : https://www.lotuseye.org/ investors All Board Directors and the designated employees have confirmed compliance with the Code.
The observation made in the Auditors Report read together with relevant notes thereon are self explanatory and hence, do not calf for any further comments under Section 134 of the Companies Act, 2013.
M/s. Anbarasu & Jalapathi, Chartered Accountants are your statutory auditors, who shall hold office till the conclusion of 25th Annual General Meeting.
CA P Vishnu Adithan, Practicing Chartered Accountant was appointed as the Internal Auditors of the Company for the financial year 2018-19 pursuant to Section 138(1) of the Act.
Pursuant to provisions of section 204 of the Companies Act, 2013 and The Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 the company has appointed P. Eswaramoorthy and Company (CP No. 7069), Company Secretaries to undertake the Secretarial Audit of the Company for the financial year 2018-19.
As required under section 204 (1) of the Companies Act, 2013 the Company has obtained a secretarial audit report. The Company Secretary in Practice has made its observation in Secretarial Audit Report (MR-3) which is annexed herewith as "Annexure - II".
EXTRACT OF ANNUAL RETURN:
The details forming part of the extract of the Annual Return in form MGT-9 is annexed here with as "Annexure III" at www.lotuseye.org".
BUSINESS RISK MANAGEMENT:
The Company has a robust Risk Management framework to identify, evaluate business risks and opportunities. This framework seeks to create transparency, minimise adverse impact on the business objectives and enhance the Companys competitive advantage. As part of the Risk Management framework, the Company reviewed periodically the various risks and finalised the mitigation plans. The identified risk areas were covered by the Internal Audit and major risks were discussed periodically.
PARTICULARS OF EMPLOYEES:
Statements containing the details as required in terms of the provisions of Section 197 of the Act read with Rule 5(1), (2) and (3) of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 are attached to this Report as "Annexure -I". During the year under review, no complaint /case was filed pursuant to Sexual Harassment of Women at workplace (Prevention, Prohibition and Redressal) Act, 2013.
CORPORATE GOVERNANCE AND MANAGEMENT DISCUSSION & ANALYSIS REPORT:
Management Discussion & Analysis Report, which form an integral part of this Report, is set out as separate annexure as "Annexure -IV".
The Corporate Governance Report together with the Certificate from the Auditors of the Company regarding compliance with the requirements of Corporate Governance as stipulated in SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 which form an integral part of this report is set out as separate annexure as "Annexure - V".
CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION, FOREIGN EXCHANGE EARNINGS AND OUTGO BIO-MEDIC AL WASTE
On an average the following quantity of waste is disposed off by the company, red waste 1 kg, yellow waste 0.27 kg and blue waste 0.7 kg.
The details of Conservation of Energy, Technology Absorption, Foreign Exchange Earnings and Outgo are as under: a) Conservation of Energy:
|Steps taken for conservation||The operation of the Company being service related, require normal consumption of electricity. The Company is taking every necessary step to reduce the consumption of energy.|
|Steps taken for utilizing alternate sources of energy||Nil|
|Capital investment on energy conservation equipments||In view of the nature of activities carried on by the Company, there is no capital investment on energy conservation equipments.|
b) Technology Absorption:
|Efforts made for technology absorption||Nil|
|Expenditure on Research & Development, if any||Nil|
|Details of technology imported, if any||Nil|
|Year of import||Nil|
|Whether imported technology fully absorbed||Nil|
|Areas where absorption of imported technology has not taken place, if any||Nil|
c) Foreign Exchange Earnings / Outgo ( in Lakhs):
Your Company and its Directors wish to extend their sincerest thanks to the Members of the Company, Bankers, State Government, local Bodies, Customers, Suppliers, Executives, Staff at all level and all other stakeholders for their continuous cooperation and assistance.
|For and on behalf of the Board|
|Place : Coimbatore|
|date : 28th May, 2019||(Sd.) S.K. Sundaramoorthy|
|Chairman cum Managing director|